|
Erlotinib Hydrochloride |
|---|---|
| Trade Name | Tarceva |
| Orphan Indication | Malignant gliomas |
| USA Market Approval | USA |
| USA Designation Date | 2003-07-18 00:00:00 |
| Sponsor | Genentech, Inc;1 DNA Way;South San Francisco, California, 94080 |
|
Erlotinib Hydrochloride |
|---|---|
| Trade Name | Tarceva |
| Orphan Indication | Malignant gliomas |
| USA Market Approval | USA |
| USA Designation Date | 2003-07-18 00:00:00 |
| Sponsor | Genentech, Inc;1 DNA Way;South San Francisco, California, 94080 |